Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

21 Nov 2019 13:00

RNS Number : 2214U
British Smaller Companies VCT2 Plc
21 November 2019
 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 30 September 2019

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 30 September 2019. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company has continued to make good progress in the quarter with Total Return rising to 120.2 pence per ordinary share. This is an increase of 1.8 pence per ordinary share and represents an increase of 3.0 per cent over the Net Asset Value ("Nav") of 59.9 pence per share at the beginning of the financial year.

Realisation of Eikon

Subsequent to the period end your Company has part-realised its investment in Eikon Holdco Limited which has resulted in a valuation uplift of £2.0 million in the quarter to 30 September 2019. The Company has to date received proceeds of £2.0 million out of a total value of £4.3 million. The balance comprises deferred consideration, loan notes and a residual equity stake. The terms of the deferred consideration are expected to result in further receipts in the near term.

Performance

The movement in Total Return in pence per ordinary share is set out in the table below:

Pence per

ordinary share

Cumulative dividends to 30 June 2019

65.0

Net Asset Value at 30 June 2019

53.4

Total Return at 30 June 2019

118.4

Net underlying increase in portfolio

1.9

Net income after expenses / share buy-backs

(0.1)

Increase in Total Return

1.8

Total Return at 30 September 2019

120.2

 

30 September 2019

Movement

30 June 2019

Net Assets (£m)

71.0

0.8

70.2

NAV per share (PPS)

53.7p

0.3p

53.4p

Cumulative dividends paid (PPS)

66.5p

1.5p

65.0p

Total Return (PPS)

120.2p

1.8p

118.4p

Shares in issue

132,200,546

688,151

131,512,395

 

The Total Return at 30 September 2019, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 120.2 pence per ordinary share compared to 118.4 pence per ordinary share at 30 June 2019.

The unaudited NAV per ordinary share as at 30 September 2019 was 53.7 pence per ordinary share (30 June 2019: 53.4 pence per ordinary share) representing an increase of 1.8 pence per ordinary share from the portfolio/net income, offset by the interim dividend of 1.5 pence per share paid on 23 September 2019.

Cumulative dividends paid were up 1.5 pence per ordinary share at 66.5 pence per ordinary share (30 June 2019: 65.0 pence per ordinary share).

The movement in NAV per ordinary share and the dividends paid are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 30 June 2019

70.2

53.4

Net underlying increase in portfolio

2.5

1.9

Net income after expenses

(0.1)

(0.1)

Issue of shares/buybacks

0.4

-

Increase

2.8

1.8

NAV before the payment of dividends

73.0

55.2

Dividends paid

(2.0)

(1.5)

NAV at 30 September 2019

71.0

53.7

 

Dividends and shares in issue

An interim dividend of 1.5 pence per ordinary share was paid on 23 September 2019. On the same date 923,151 ordinary shares were issued under the Company's DRIS.

On 26 September 2019 the Company purchased 235,000 ordinary shares of 10 pence each at a price of 49.81 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 30 September 2019 was 132,200,546 (30 June 2019: 131,512,395). In addition, at 30 September 2019 the Company held 8,209,092 ordinary shares in treasury (30 June 2019: 7,974,092).

 

Net assets

Net assets at 30 September 2019 comprised the following:

£000

% of net assets

Unquoted investments at fair value

45,351

63.9%

Quoted investments at bid price

226

0.3%

Total investments

45,577

64.2%

Cash and cash equivalents

24,322

34.3%

Other net current assets

1,067

1.5%

Net assets

70,966

100%

 

The investment portfolio at 30 September 2019 was comprised as follows:

Valuation

£000

Valuation as a % of net assets

ACC Aviation Group Limited

6,479

9.1%

Matillion Limited

5,489

7.7%

Eikon Holdco Limited

4,331

6.1%

Intelligent Office UK Limited

3,142

4.4%

Business Collaborator Limited

2,847

4.0%

KeTech Enterprises Limited

2,311

3.3%

Springboard Research Holdings Limited

1,759

2.5%

Tonkotsu Limited

1,592

2.3%

Deep-Secure Limited

1,515

2.1%

Wooshii Limited

1,440

2.0%

30,905

43.5%

Other investments

14,672

20.7%

Total investments

45,577

64.2%

 

Although there were no investments during the quarter, subsequent to the quarter end the Company invested £1.5 million into SharpCloud Software Limited, which has developed an enterprise software product that is a visualisation and collaboration tool for large organisations and made a small further investment into Ncam Technologies Limited.

In the quarter to 30 September 2019 the realisation and repayment of investments generated cash proceeds of £0.7 million.

Investments made prior to the November 2015 Budget represented 53 per cent of the value of the unquoted portfolio at 30 September 2019.

Portfolio Performance

Over the quarter to 30 September 2019 the aggregate unrealised portfolio valuation has increased by £2.5 million. The Board continues to follow its policy of maintaining a diversified portfolio. At 30 September 2019, only three investments represented more than 5 per cent of the Company's NAV, the largest being 9.1 per cent, with the top ten investments representing 43.5 per cent of NAV (30 June 2019 40.2 per cent).

Outlook

It is pleasing that Total Return has increased further in the third quarter against a background of political change and economic uncertainty. The portfolio businesses continue to invest and grow and your Company will to continue to fund this as appropriate. The level of investment enquiries remains strong and the speed of conversion has been helped because of your Company's ability to self-assure under HMRC's revised guidelines.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

21 November 2019

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Robert Naylor Panmure Gordon (UK) Limited Tel: 0207 886 2768

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRTDMMZMGMMGLZM
Date   Source Headline
23rd Sep 201910:10 amRNSPayment of Dividend and Issue of Equity
14th Aug 20199:14 amRNSHalf-year Report
10th May 20199:43 amRNSPayment of Final Dividend and Issue of Equity
7th May 20192:18 pmRNSResult of AGM and Change of Chairman
7th May 20199:53 amRNSInterim Management Statement
4th Apr 201912:13 pmRNSDirector/PDMR Shareholding
4th Apr 201912:13 pmRNSDirector/PDMR Shareholding
4th Apr 201912:11 pmRNSDirector/PDMR Shareholding
4th Apr 201912:10 pmRNSDirector/PDMR Shareholding
1st Apr 20193:51 pmRNSIssue of Equity
1st Apr 20193:44 pmRNSIssue of Equity and Close of Offers
27th Mar 201910:19 amRNSTransaction in Own Shares and Net Asset Value
26th Mar 20194:29 pmRNSPublication of Supplementary Prospectus
26th Mar 20194:27 pmRNSPublication of Supplementary Prospectus
22nd Mar 201911:48 amRNSAnnual Financial Report
6th Mar 201911:09 amRNSAppointment of non-executive director
15th Feb 20199:56 amRNSPayment of interim dividend and issue of shares
11th Feb 201911:15 amRNSClose of Offers to New Applications
11th Feb 201911:15 amRNSClose of Offers to New Applications
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
7th Jan 20192:15 pmRNSDividend Declaration
7th Jan 20191:15 pmRNSStatement re Prospectus
7th Jan 20191:15 pmRNSStatement re Prospectus
21st Dec 20189:13 amRNSDisposal
20th Dec 201810:20 amRNSTransaction in Own Shares
27th Nov 20186:07 pmRNSPublication of Prospectus
27th Nov 20185:49 pmRNSPublication of Prospectus
21st Nov 20181:00 pmRNSUnaudited Interim Results to 30 September 2018
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
28th Sep 20189:54 amRNSPayment of dividend and allotment of shares
27th Sep 20181:27 pmRNSTransaction in Own Shares
17th Aug 20188:07 amRNSHalf-year Report
25th Jun 201811:52 amRNSTransaction in Own Shares
11th May 201810:01 amRNSPayment of final dividend and allotment of shares
9th May 20182:36 pmRNSResult of Annual General meeting
9th May 20189:54 amRNSInterim Management Statement
28th Mar 20188:27 amRNSTransaction in Own Shares
16th Mar 20181:43 pmRNSAnnual Financial Report
16th Feb 20189:50 amRNSIssue of Equity
12th Feb 201810:50 amRNSDirector Declaration
26th Jan 20189:24 amRNSClose of Offer to New Subscriptions
11th Jan 20188:06 amRNSOffer for Subscription
20th Dec 20178:50 amRNSPurchase of own securities and total voting rights
20th Dec 20178:50 amRNSLaunch of Top-up Offer
30th Nov 20171:28 pmRNSInterim Management Statement to 30 September 2017
20th Oct 20172:12 pmRNSTransaction in Own Shares
29th Sep 20179:47 amRNSPayment of interim dividend and issue of shares
29th Sep 20179:36 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.